Positive preliminary results from the Rapid Paediatric Sequencing Project

28 Jun 2016, 1:56 p.m.

senior clinician

The Rapid Paediatric Sequencing Project (RaPs) is a pilot project aimed at evaluating the use of rapid whole genome sequencing (WGS) for rare diseases in a clinical setting. Successful results have been received from the first patients to have taken part.

The pilot phase of this project aims to identify 10 patients (run as family trios – a patient plus their two parents) from the paediatric intensive care unit (PICU) at Great Ormond Street Hospital (GOSH).

To date, a total of eight patients have been successfully enrolled. These patients were identified as having immediate clinical need, presented with a phenotype of genetic aetiology and for whom the rapid identification of a causative gene could have a positive impact on their clinical management.

The Rapid Paediatric Sequencing pipeline begins with patients being identified by a senior clinician on PICU. Blood samples are then collected from the patients which then undergo DNA extraction and sequencing.

Preliminary results show that actionable findings could be returned to the PICU clinicians within five days of the initial consent. Of the patients processed so far, clinicians have identified three genes known to cause the underlying disease and two genes that are candidates for the disease. This project is run by GOSgene, which is wholly funded by the NIHR Great Ormond Street BRC.

Help pioneer new treatments for millions of people this DNA Day

DNA Day is coming up this Thursday (25 April) and the team behind the DNA, Children + Young People’s Health Resource (D-CYPHR) are encouraging children and young people to contribute to important health research.

New study finds that nasal cells protect against Covid-19 in children

New research shows that children are less likely than adults to develop severe COVID because cells in their nose are better at fighting off the virus.

New plan announced to get more children access to gene therapy treatments

Great Ormond Street Hospital (GOSH) has announced plans to revolutionise how children living with a rare disease can gain access to life-changing treatments.

First-of-its-kind study into the Ketogenic diet

A ketogenic diet, which is low in carbohydrates and high in fat, shows promise as an alternative treatment option for infants with drug-resistant epilepsy.